BIS icon

ProShares UltraShort NASDAQ Biotechnology

5 hedge funds and large institutions have $691K invested in ProShares UltraShort NASDAQ Biotechnology in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TRCT
1
Tower Research Capital (TRC)
New York
$397K 19,784 +2,199 +13%
OMC
2
Old Mission Capital
Illinois
$266K 13,257 +13,257 New
UBS Group
3
UBS Group
Switzerland
$18K 886 -2,140 -71%
Morgan Stanley
4
Morgan Stanley
New York
$8K 381 +200 +110%
Citigroup
5
Citigroup
New York
$2K 85
IMC Chicago
6
IMC Chicago
Illinois
-27,459 Closed
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
-21,506 Closed
CFGS
8
Concourse Financial Group Securities
Alabama